H. Phan

Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non‐ambulatory males with Duchenne muscular dystrophy from MD STARnet

N. Johnson, R. Butterfield, M. Feldkamp, 2022, Muscle & nerve.

A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial

R. Finkel, K. Mathews, J. Statland, 2021, Journal of neuromuscular diseases.

Association of genetic mutations and loss of ambulation in childhood‐onset dystrophinopathy

Maureen K. Galindo, S. Pandya, Gregory Haber, 2020, Muscle & nerve.

P.132 Casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: Interim results from the Phase 3 ESSENCE trial

V. Straub, J. Malhotra, F. Muntoni, 2022, Neuromuscular Disorders.